Healthcare -
Biotechnology - NASDAQ - US
$ 34.06
0.889 %
$ 13.1 B
Market Cap
-5.86
P/E
MRNA - COST OF REVENUE
Cost of Revenue MRNA - Moderna, Inc.
4.69 B
LAST VALUE
33.91%
2 YEAR CAGR
59.54%
5 YEAR CAGR
0.00%
10 YEAR CAGR